Anger H, Gleissenberger U
Geburtshilfe Frauenheilkd. 1977 Jul;37(7):604-8.
The concentration of carcino-embryogenic antigen in the serum of healthy women and of patients with different benign and malignant genital tumors was determined before and after treatment. The carcino-embryogenic antigen was elevated to more than 2.5 ng/ml in 11% of the healthy control patients. Patients with carcinoma of the breast had positive CEA tests in 60%. Patients with ovarian cancer had positive CEA tests in 57%, women with carcinoma of the uterine cervix had positive tests in 50% and women with endometrial carcinoma had increased CEA levels in the serum in 38% of the cases. Following treatment the CEA values decreased.
测定了健康女性以及患有不同良性和恶性生殖器肿瘤患者治疗前后血清中癌胚抗原的浓度。11%的健康对照患者癌胚抗原升高至超过2.5 ng/ml。乳腺癌患者中60%癌胚抗原检测呈阳性。卵巢癌患者中57%癌胚抗原检测呈阳性，宫颈癌女性患者中50%检测呈阳性，子宫内膜癌女性患者中38%血清癌胚抗原水平升高。治疗后癌胚抗原值下降。
